Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
923.1 INR | -2.05% | -2.83% | +21.56% |
May. 30 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
May. 09 | Transcript : Alembic Pharmaceuticals Limited, Q4 2024 Earnings Call, May 09, 2024 |
Business Summary
Number of employees: 14,593
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Formulations
79.4
%
| 43,673 | 82.3 % | 44,871 | 79.4 % | +2.74% |
Active Pharmaceutical Ingredients
20.6
%
| 9,385 | 17.7 % | 11,655 | 20.6 % | +24.19% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
100.0
%
| 53,058 | 100.0 % | 56,526 | 100.0 % | +6.54% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 83-04-30 | |
Director of Finance/CFO | 64 | 03-01-17 | |
Manisha Saraf
CMP | Compliance Officer | - | 23-03-31 |
Director/Board Member | 48 | 06-12-31 | |
Director/Board Member | 46 | 11-03-30 | |
Ajay Kumar Desai
PRN | Corporate Officer/Principal | - | 08-08-31 |
Mitanshu Shah
PRN | Corporate Officer/Principal | - | 06-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 83-04-30 | |
Director of Finance/CFO | 64 | 03-01-17 | |
Director/Board Member | 56 | 15-02-03 | |
Director/Board Member | 46 | 11-03-30 | |
Director/Board Member | 66 | 22-02-09 | |
Director/Board Member | 48 | 06-12-31 | |
Director/Board Member | 51 | 23-05-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 196,563,124 | 57,547,288 ( 29.28 %) | 0 | 29.28 % |
Company contact information
Alembic Pharmaceuticals Ltd.
Alembic Road
390003, Vadodara
+91 26 5663 7000
http://alembicpharmaceuticals.comSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.56% | 2.17B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- APLLTD Stock
- Company Alembic Pharmaceuticals Limited